Stock News
Concert Pharmaceuticals Could Have First Oral Drug For Patients With Sudden Hair Loss – Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)
Concert Pharmaceuticals (CNCE) is looking to have a good 2019 if things go well for its phase 2 study using CTP-543 to treat patients with alopecia areata. Here is the kicker: the 8 mg dose […]
